Updates

Treatt - Trading substantially ahead of forecasts

March 2017

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Treatt shot up by 20% after the company said that the combination of strong growth in revenues (20%+ year on year) and new business wins for its higher margin ingredient solutions means it will substantially exceed market expectations. H1 results will be announced on 9 May.A main write up in the November issue. With its business in areas such as sugar free solutions, Treatt looks set for a new upgrade cycle. Keep on buy list. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

On the Beach - New highs for shares as first four month sales jump +20%

Innovaderma - Beauty of the internet age

Treatt (May 2023)

Treatt (September 2022)

Treatt - Explosive growth trajectory; gain 336% (March 2021)

Treatt - 95% gain since our main write up in November â€˜16 (February 2018)

Treatt - To exceed even recently upgraded forecasts (May 2017)

Treatt - Sugar free flavourings take off (November 2016)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X